![]() |
|
|
Vol. 298, Issue 3, 1167-1171, September 2001
Department of Pharmacobiology, Faculty of Pharmacy, University of Bari, Bari, Italy
| |
Abstract |
|---|
|
|
|---|
Emerging evidence supports the idea that taurine exerts some of its
actions through inhibition of inward rectifier K+ channels,
ATP-sensitive K+ channels, and voltage-dependent
K+ channels. However, to date not much is known about the
effects of this sulfonic amino acid on Ca2+-activated
K+ (KCa2+) channels, which are widely
expressed in various tissues, including skeletal muscle. In the present work, the effects of taurine on KCa2+ channels of rat
skeletal muscle fibers were investigated using the patch-clamp technique. The application of the amino acid to the internal side of
the excised macropatches induced a dose-dependent decrease in the
outward KCa2+ currents recorded at positive membrane
potentials in the presence of 8 to 16 µM concentrations of free
Ca2+ ions in the bath with an IC50 of 31.9 · 10
3 ± 1 M (slope factor = 1.2)
(n = 11 patches). In contrast, at negative
membrane potentials taurine caused an enhancement of the muscular
inward KCa2+ currents with a DE50 (drug concentration needed to enhance the current by 50%) of 46.7 · 10
3 ± 2 M (slope factor = 1.3)
(n = 9 patches). Single channel analysis revealed that
this effect was mediated by changes in the reversal potential of the
KCa2+ channel for K+ ions with no changes
in the gating properties or in the sensitivity of the channel to
Ca2+ ions. Taurine also did not affect the single channel
conductance. In conclusion, taurine shows a voltage-dependent dualistic
action on KCa2+ channels, being an inhibitor of the
channel at positive membrane potentials and an activator at negative
membrane potentials.
| |
Introduction |
|---|
|
|
|---|
In
the last few years, the attention of several laboratories has been
focused on the investigation of the cellular mechanisms by which
taurine, a well known sulfonic amino acid abundantly distributed in
different tissues including skeletal muscle, exerts its effects. This
comes from the fact that taurine shows several interesting properties,
such as antioxidant, osmo-regulator control of the
Ca2+ homeostasis and antischemic properties
(Huxtable and Sebring, 1986
; Conte Camerino et al., 1989
;
Pasantes-Morales et al., 1998
). "In vivo" studies have also shown
that taurine antagonizes the age-dependent impairment of the
contractility function of skeletal muscle fibers in aged rats (Pierno
et al., 1998
).
Emerging evidence indicates that taurine exerts its actions by
interacting with different ion channels, including
K+ channels (Conte Camerino et al., 1989
; Satoh,
1998a
). For example, taurine inhibits the inward rectifier
K+ channel of isolated cardiomyocytes by reducing
the channel open probability without affecting the single channel
conductance (Satoh, 1998b
). ATP-sensitive K+
(KATP) channels of cardiac and skeletal muscle
fibers are also inhibited by the sulfonic amino acid. In fact, we have
shown that taurine induces a reversible inhibition of the muscular
KATP channel interacting with the sulfonylurea
receptor (SUR) subunit without affecting the Ca2+
binding site (Tricarico et al., 2000a
). In the case of
voltage-dependent K+ channels, the action of
taurine has been described to be Ca2+-dependent;
in fact, the amino acid behaves as an agonist of the cardiac delayed
rectifier K+ channel at low internal
Ca2+ concentrations (10
8
M) and as an antagonist in the presence of a high internal
Ca2+ concentration (10
6
M) (Satoh, 1998a
).
The physiological significance of the observed inhibitory effects shown
by taurine on different classes of K+ channels
remains to be elucidated. One possibility is that taurine can serve to
protect the fibers against ischemic insults. In fact, a release of the
amino acid occurs during periods of ischemia reperfusion in cardiac
fibers, and this would allow the opening of KATP
channels and other K+ channels with rapid
repolarization of the fibers and cytoprotective effects (Allo et al.,
1997
; Suleiman et al., 1997
; Saransari and Oja, 1998
; Tricarico et al.,
2000a
).
Although some of the therapeutic effects of this amino acid appear to
involve the interaction of taurine with different classes of
K+ channels, currently no data is available on
the action of taurine on another type of K+
channel widely expressed in the tissues, including skeletal muscle, the
Ca2+-activated K+
(KCa2+) channels. The opening of this type of channel,
triggered by cellular depolarization and elevated intracellular Ca2+ ions in the excitable tissues, increases the
duration of the hyperpolarization phase between bursts of action
potentials, reducing the firing capability of the fibers (Hille, 1984
;
Tricarico et al., 1997
). This helps to reduce the intracellular
accumulation of Ca2+ ions occurring during bursts
of action potentials in the fibers. However, persistent abnormal
opening of muscle KCa2+ channels may also lead to the
accumulation of K+ ions inside the t-tubule
during muscle contraction, thus contributing to the phenomenon known as
muscle fatigue.
In the present work, the effects of different concentrations of taurine applied "in vitro" on the intracellular face of patches excised from native skeletal muscle fibers were investigated using the patch-clamp technique on KCa2+ channels.
| |
Materials and Methods |
|---|
|
|
|---|
Muscle Preparations and Single Fiber Isolation.
The
flexor digitorum brevis (FDB) muscles were dissected from the
rats under urethane anesthesia (1.2 g/kg). After dissection, the
animals were rapidly killed with an overdose of urethane according to
the Guide for Care and Use of Laboratory Animals prepared by the National Academy of Sciences (Washington, DC). Single muscle fibers were prepared from FDB muscles by enzymatic dissociation, as
previously described (Tricarico and Conte Camerino, 1994
).
Drugs and Solutions.
The normal Ringer's solution
contained 145 mM NaCl, 5 mM KCl, 1 mM MgCl2, 0.5 mM CaCl2, 5 mM glucose, and 10 mM MOPS, pH = 7.2. The patch-pipette solution contained 150 mM KCl, 2 mM
CaCl2, and 10 mM MOPS, pH = 7.2. The bath
solution contained 150 or 30 mM KCl, 5 mM EGTA, and 10 mM MOPS, pH = 7.2. CaCl2 was added to the bath solution to
give a free Ca2+ ion concentration of 8 µM or
16 µM. The calculations of the free Ca2+ ion
concentration in the bath were performed as previously described (Tricarico et al., 1997
, 2000b
). Taurine was dissolved in the bath
solution and tested in a range of concentrations from
10
5 to 1.5
1 M. The
possible influence of the osmolarity on KCa2+ channels
was evaluated by applying a bath solution enriched with sucrose
(20-100 mM) to the internal side of the excised patches. No
significant effects were observed after the addition to the bath of a
solution containing 20 to 100 mM concentrations of sucrose.
Patch Pipettes. The patch pipettes were prepared as previously described. Pipettes, having an average tip opening area of 5.7 ± 0.6 µm2 (macropatches = 23), were used to measure the current sustained by multiple KCa2+ channels and their pharmacological properties. Moreover, the single channel conductance and the gating properties of the channels per unit area were measured using pipettes having a tip opening area of 0.9 ± 0.2 µm2 (patches = 12).
Patch-Clamp Experiments.
Experiments were performed in
inside-out configurations using the standard patch-clamp technique.
Recordings of macropatch KCa2+ currents were performed
at 20°C, at different voltages (from
60 to +30 mV) of membrane
potentials (Vm), for time periods of
300 to 400 s immediately after excision, with 150 mM KCl on both
sides of the membrane, and in the presence of 8 or 16 µM
concentrations of free Ca2+ ions in the bath
solution (Tricarico et al., 1997
, 2000b
). Single channel recordings
were performed at 20°C, at
60 mV or +30 mV of membrane potentials,
for 120 to 200 s, and during voltage steps from 0 mV of holding
potential to
70 and +70 mV (Vm). The
macropatch currents and single channel currents were recorded at 1 kHz
(filter = 0.2 kHz) and 20 kHz (filter = 2 kHz) of sampling
rates, respectively, using an Axopatch-1D amplifier equipped with a
CV-4 headstage (Axon Instruments, Foster City, CA).
Analysis of the Macropatch Current and Single Channel
Current.
The KCa2+ currents flowing through the
macropatches excised from different FDB fibers were digitally averaged and were calculated by subtracting the baseline level of the currents from the open channel level, as previously described (Tricarico et al.,
1997
, 2000b
). The baseline level for KCa2+ current was
measured in the absence of free Ca2+ ions in the
bath. The criteria for accepting the data entering within the digital
average were based on the stability of the seal, the possible noises,
and the presence of currents different from KCa2+
current. Macropatches containing voltage-gated K+
channels or inward rectifier K+ channels were
excluded from the analysis. Currents from voltage-gated K+ channels or inward rectifier
K+ channels were identified on the basis of their
single channel conductance, voltage dependence, and lack of stimulation
by Ca2+ ions. For example, the most common
voltage-gated K+ channels active in our patches
showed single conductance ranging between 10 and 19 pS and were
identified in the absence of intracellular free
Ca2+ ions during voltage steps going from
80 or
100 mV to depolarizing voltages, whereas inward rectifier
K+ channels showed single channel conductance
ranging between 10 and 40 pS and were identified in the absence of
internal free Ca2+ ions at negative membrane
potentials. KATP channels are inhibited by
micromolar concentrations of Ca2+ ions (Tricarico
et al., 2000a
). The single channel current of KCa2+
channels was measured using the cursor method provided by the Fetchan
program (Axon Instruments). The single channel conductance was
calculated as the slope of the voltage-current relationship of the
channel in the range of potentials from
70 to +70 mV. No correction
for liquid-junction potential was made, and it was estimated to be <1
mV in our experimental conditions.
Statistics.
The data are expressed as mean ± S.E.
unless otherwise specified. The concentration-response relationship of
KCa2+ currents versus drug concentrations constructed
at a positive membrane potential of +30 mV and describing the
antagonist action of taurine on KCa2+ channels fit the
following equation: (Idrug
Icontrol)/Icontrol = E/(1 + ([Drug]/IC50)n), whereas
the concentration-response relationship of KCa2+ currents versus drug concentrations constructed at a negative membrane
potential of
60 mV and describing the agonist action of taurine on
KCa2+ channels fit the following equation:
(Idrug
Icontrol)/Icontrol = E/(1 + (DE50/[Drug])n), where
(Idrug
Icontrol)/Icontrol
is the ratio between the current measured in the presence of drug and
that measured in the absence of drug; E is the observed
effects (inhibition or activation) of the drugs on
KCa2+ channels; DE50 is the
concentration of the drug needed to enhance the current by 50%;
[Drug] is the concentration of the drug tested; n is the slope of the curves; and IC50 is the
concentration of the drug needed to reduce the currents by 50%. The
algorithms of the fitting procedures used were based on the Marquardt
least-squares fitting routine.
| |
Results |
|---|
|
|
|---|
The application of increasing concentrations of taurine to the
macropatches excised from rat skeletal muscle fibers provoked a
dose-dependent decrease in the muscle KCa2+ outward
currents recorded at a positive membrane potential of +30 mV
(Vm) in the presence of an 8 µM
concentration of free Ca2+ ions in the bath. For
example, the outward currents were decreased by 39 and 62% with
20 · 10
3 and 60 · 10
3 M concentrations of taurine, respectively
(Fig. 1A). The IC50 of taurine calculated using the fitting routine was 31.9 · 10
3 ± 1 M (slope factor = 1.2)
(n = 11 patches) (Fig. 1B).
|
In contrast, at negative membrane potentials in the presence of an 8 µM concentration of free Ca2+ ions in the bath,
taurine exerted an opposite effect on muscle KCa2+
currents. In fact, 20 · 10
3 and 60 · 10
3 M concentrations of the sulfonic amino
acid enhanced the inward KCa2+ current, increasing it
by 56 and 67% at
40 mV (Vm), and 31 and 43% at
60 mV (Vm),
respectively. The DE50 of taurine calculated
using the fitting routine was 46.7 · 10
3 ± 2 M (slope factor = 1.3) (n = 9 patches)
(Fig. 1B). In the absence of internal Ca2+
ions, taurine did not induce activation of KCa2+ currents at negative membrane potentials.
Single channel recordings revealed that the dualistic effects of
taurine on KCa2+ currents observed at negative and
positive membrane potentials were mainly due to changes in the reversal
potential of KCa2+ channel to K+
ions (Fig. 2). This was demonstrated by
taurine causing a dose-dependent rightward shift of the current-voltage
relationship of the KCa2+ channel from
0.3 mV in the
absence of taurine to +9.3 ± 2 and +16 ± 3 mV in the
presence of 20 · 10
3 and 60 · 10
3 M concentrations of the sulfonic amino
acid, respectively. Accordingly, 20 · 10
3 and 60 · 10
3
M concentrations of taurine reduced the single channel current at +30
mV (Vm) by 42 and 65%, while
increasing it by 32 and 44% at
60 mV
(Vm), respectively. The changes in the
single channel currents observed following taurine application to the
excised patches matched those observed in the macropatch currents.
|
No changes were observed in the single channel conductance following
the in vitro application of 20 · 10
3 and
60 · 10
3 M concentrations of taurine to
the patches containing KCa2+ channels. Indeed, the
slope conductance calculated from the current-voltage relationships for
the KCa2+ channel was 221 ± 12 pS (n
patches = 8) in the controls and 228 ± 9 pS (n = 9 patches) and 222 ± 10 pS (n = 9 patches) in the
presence of 20 · 10
3 and 60 · 10
3 M concentrations of taurine, respectively
(Fig. 2).
Taurine did not affect the long-term gating properties of the
KCa2+ channel. In fact, the application of a 30 · 10
3 M concentration of the sulfonic amino
acid to excised patches containing multiple KCa2+
channels did not alter the gating or the number of functional channels
per patch area at positive or negative membrane potentials (Fig.
3, A-D). Furthermore, taurine did not
alter the sensitivity of the KCa2+ channel to
Ca2+ ions, which is demonstrated by the fact that
the gating and the number of functional channels per patch area were
unchanged after application of a 30 · 10
3 M concentration of taurine to the patches
at positive or negative membrane potentials.
|
In our experimental condition, taurine did not affect leak currents
(Fig. 3, B and C). Concentrations of taurine lower than 5 · 10
3 M did not alter the macroscopic or
microscopic properties of the KCa2+ channel.
| |
Discussion |
|---|
|
|
|---|
We found that taurine applied on the intracellular face of the
membrane patches excised from skeletal muscle fibers induced two
opposite effects on sarcolemma KCa2+ currents. At
positive membrane potentials, the outward KCa2+ currents decreased, whereas at negative membrane potentials, the sulfonic amino acid induced stimulation of inward
KCa2+ currents. This is the result of the rightward
shift of the reversal potential of the KCa2+ channel
for K+ ions caused by taurine. Changes in the
reversal potentials of ion channels may be related to modifications of
the selectivity of the pore to K+ ions, to
alteration of the surface charge potentials, and/or to changes in the
local charge density (Hille, 1984
). In our study, the observation that
taurine altered the reversal potential of the KCa2+
channel for K+ ions without affecting the single
channel conductance supports the hypothesis that the effects of the
amino acid are related to changes in the surface charge potentials
and/or change in the local charge density rather than to changes in the
selectivity of the pore for K+ ions. It is
possible that taurine affected the local charge density by binding to
charge residues located at the mouth of the pore of the
KCa2+ channel reducing the accessibility of
K+ ions from the intracellular side of the
membrane to the conduction pathway. In our experiments, the finding
that the slope factor calculated by the fitting routine was about 1 for
both the inhibition and activation of the KCa2+
channel by the sulfonic amino acid suggests that the stoichiometry of
the interaction of taurine with the binding site is 1:1.
Similarly, a shift of the reversal potentials of the cardiac
inward rectifier K+ channel and the embryonic
Na+ channel toward more negative potentials
following extracellular taurine application has also been described
(Satoh, 1995
, 1998b
). This is not surprising considering that taurine
is a charged amino acid capable of altering surface charge potentials
by interacting with the polar phase of phospholipids. If the site(s) of
interaction are located in the ion channel pore on residues critical
for the conduction pathway, modification of the reversal potentials for the carried ion can be expected. Alternately, if the site of
interaction of taurine is located in proximity to subunits critical for
controlling channel activity and the pharmacological properties of the
channel, changes in gating and in the response of the channel to drugs can be expected. This phenomenon occurs in the case of the action of
taurine on muscle KATP channels in which the
sulfonic amino acid induces a reversible inhibition of the muscular
channel interacting with a site allosterically coupled to the SUR of
the KATP channel complex at the interface between
the membrane phospholipids and the SUR protein without altering the
reversal potential for K+ ions (Tricarico et al.,
2000a
).
From a pharmacological point of view, taurine can therefore be
considered an inhibitor of several classes of K+
channels, including Ca2+-activated
K+ channels. In skeletal muscle, the capability
of the sulfonic amino acid to reduce the outward KCa2+
current, even in the presence of the natural stimulatory ligand of the Ca2+ ions, may have important implications in
those conditions associated with hyperkalemic states, such as
ischemia-reperfusion and muscle fatigue, or in cases of an impairment
of muscle contraction, such as the aging process (Pierno et al., 1998
).
The action of taurine, through inhibition of the outward currents
carried by KCa2+ channels, would reduce the
hyperpolarization phase following the firing of action potentials, thus
controlling the Ca2+ homeostasis of the fibers
and contributing to Ca2+-dependent physiological
functions, such as muscle contraction. This corresponds with the fact
that taurine supplementation shows therapeutic effects, improving the
contractility functions of aged rat skeletal muscle (Pierno et al.,
1998
).
We believe that the agonist action shown by taurine at negative
membrane potentials on inward currents of KCa2+ channels may have implications in those pathophysiological conditions associated with taurine depletion, such as ischemia-reperfusion in
which a loss of taurine can favor the opening of KCa2+ channels and other K+ channels with fiber
repolarization and cytoprotective effects (McPherson et al., 1993
;
Hearse, 1995
; Han et al., 1996
; Tricarico et al., 2000a
). This
corresponds with the observation that the loss of taurine from the
tissues is considered as a protective mechanism against ischemia (Allo
et al., 1997
; Suleiman et al., 1997
).
| |
Footnotes |
|---|
Accepted for publication May 15, 2001.
Received for publication February 12, 2001.
The financial support of Cofin-Ministero dell' Università e della Ricerca Scientifica e Tecnologica (MURST)1998-2000 is gratefully acknowledged.
Address correspondence to: Prof. Diana Conte Camerino, Unit of Pharmacology, Department of Pharmacobiology, Faculty of Pharmacy, University of Bari, 70126, via Orabona no. 4, Bari, Italy. E-mail: conte{at}farmbiol.uniba.it
| |
Abbreviations |
|---|
KATP, ATP-sensitive K+ channel; SUR, sulfonylurea receptor; KCa2+, Ca2+-activated K+ channel; MOPS, 3-(N-morpholino)propanesulfonic acid; Vm, membrane potential; DE50, drug concentration needed to enhance the current by 50%; FDB, flexor digitorum brevis.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
C. A. Goodman, D. Horvath, C. Stathis, T. Mori, K. Croft, R. M. Murphy, and A. Hayes Taurine supplementation increases skeletal muscle force production and protects muscle function during and after high-frequency in vitro stimulation J Appl Physiol, July 1, 2009; 107(1): 144 - 154. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||